MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Healthcare experiences of People with Parkinson’s Disease (PwP) during COVID-19 pandemic

V. Tomantschger, A. Tautscher-Basnett, C. Hohenwarter (Hermagor, Austria)

Meeting: 2023 International Congress

Abstract Number: 1921

Keywords: Anxiety, Parkinson’s, Rehabilitation

Category: Quality Of Life/Caregiver Burden in Movement Disorders

Objective: To investigate how our group of PwP coped with healthcare issues during the pandemic.

Background: COVID-19 pandemic led to changes in how healthcare services were delivered. Non-essential services were cancelled; obligatory testing, mandatory vaccination or compulsory masks added to the challenges of suffering from a progressive neurological disease such as Parkinson’s (PD).

Method: Questionnaire covering the period 03/2020–12/2022 (34 months) with 10 multiple choice and 2 open questions for personal comments. 293 questionnaires were sent by post to PwP known at our neurorehabilitation centre in Austria. 58% return rate, of these: 6 invalid, thus 164 valid responses. Age range 50-90 yrs (64% were over 71 yrs old); 63% male, 37% female; all stages of Hoehn & Yahr.

Results: 79% were on oral treatment, 5 % non-oral, 16% combination of oral and non-oral. Of the PwP on non-oral treatment 73,5% pump treatment (=25 PwP), all of them received home visits from their product specialists, only 2 with a lesser frequency. During the observation period only 45,7% reported a change in medication. 91,4% PwP had checkups with their neurologist and 95,1% with their general practitioner, most of them by personal contact. Nevertheless, 8,6% had no contact with a neurologist and 4,9% with their general practitioner. 80 patients had to have treatment in hospital, of them 52,4% experienced a variety of barriers (e.g. fear, no admission, etc.). Before the pandemic 60% had regular therapy with the allied health professions (most popular: physiotherapy), this reduced to 47% during the pandemic. 96% maintained social contacts within the close family, but 60% suffered from decreased frequencies of social contacts. A wide variety of open comments hint at problems with legislation, communication of information, visiting hours in health care establishments, personal treatment if not vaccinated, etc.

Conclusion: A neurodegenerative disease such as PD needs regular monitoring by neurologists and quality of life is influenced positively by non-medical treatment and social interaction. Our sample of PwP showed that despite many barriers encountered, treatment by health care professionals was mostly delivered, however reduced social and professional contacts were seen as problems. Being able to voice personal opinions in addition to multiple choice answers was generally regarded positively.

To cite this abstract in AMA style:

V. Tomantschger, A. Tautscher-Basnett, C. Hohenwarter. Healthcare experiences of People with Parkinson’s Disease (PwP) during COVID-19 pandemic [abstract]. Mov Disord. 2023; 38 (suppl 1). https://www.mdsabstracts.org/abstract/healthcare-experiences-of-people-with-parkinsons-disease-pwp-during-covid-19-pandemic/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2023 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/healthcare-experiences-of-people-with-parkinsons-disease-pwp-during-covid-19-pandemic/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley